Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort.
Lotte van OuwerkerkDiane van der WoudeTheo RispensCornelia F AllaartThomas Wj HuizingaPublished in: Scandinavian journal of rheumatology (2022)
Approximately 30% of patients who had reported COVID-19-like symptoms had SARS-CoV-2 antibodies. The seroprevalence of SARS-CoV-2 antibodies after reported COVID-19-like symptoms was similar in IMIDT patients with and without imed compared to controls.